Does RISANKIZUMAB-RZAA Cause Peripheral swelling? 633 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 633 reports of Peripheral swelling have been filed in association with RISANKIZUMAB-RZAA. This represents 1.0% of all adverse event reports for RISANKIZUMAB-RZAA.
633
Reports of Peripheral swelling with RISANKIZUMAB-RZAA
1.0%
of all RISANKIZUMAB-RZAA reports
8
Deaths
231
Hospitalizations
How Dangerous Is Peripheral swelling From RISANKIZUMAB-RZAA?
Of the 633 reports, 8 (1.3%) resulted in death, 231 (36.5%) required hospitalization, and 1 (0.2%) were considered life-threatening.
Is Peripheral swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 633 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Peripheral swelling?
ADALIMUMAB (13,837)
ETANERCEPT (12,654)
METHOTREXATE (10,632)
TOCILIZUMAB (8,030)
TOFACITINIB (7,830)
ABATACEPT (7,561)
LEFLUNOMIDE (7,254)
LENALIDOMIDE (6,364)
HYDROXYCHLOROQUINE (6,128)
RITUXIMAB (5,977)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Peripheral swelling Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA